Accent MicrocellNSE:ACCENTMIC +0.26%19 ROE % is 18.44% as of Mar. 2025, which is 8% below its 10-year median of 20.07. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 935 Drug Manufacturers companies, Accent Microcell ranks better than 84.39% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Accent Microcell ROE % Related Terms
Accent Microcell ROE % Historical Data
* Premium members only.
The historical data trend for Accent Microcell's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell ROE % Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
ROE %
18.04
20.07
29.65
28.16
18.44
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
ROE %
18.04
20.07
29.65
28.16
18.44
NSE:ACCENTMIC vs ZTS, UTHR: ROE % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell ROE % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's ROE % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is one times the annual (Mar. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Accent Microcell (NSE:ACCENTMIC) has a ROE % of 18.44% as of Mar. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Accent Microcell and its competitors. This is near median its historical median of 20.07. Over the past decade, Accent Microcell's ROE % has ranged from 18.04 to 29.65. According to the industry distribution chart, Accent Microcell ranks #146 out of 935 companies in the Drug Manufacturers industry, placing it in the top 15.6%.
Is Accent Microcell's ROE % too high?
Accent Microcell's current ROE % of 18.44% is near median its 10-year median of 20.07. Over the past 10 years, this metric has ranged from a low of 18.04 to a high of 29.65. The Drug Manufacturers industry median ROE % is 6.00. Accent Microcell's value of 18.44% is 207.3% above this industry median. Based on the distribution chart, Accent Microcell ranks #146 out of 935 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's ROE % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #146 out of 935 companies for ROE %. This places Accent Microcell in the top 16% of its industry — outperforming the majority of peers. The industry median ROE % is 6.00. Accent Microcell's value of 18.44% is 207.3% above this benchmark. Historically, Accent Microcell's own ROE % has ranged from 18.04 to 29.65 over the past decade. While the company's 10-year median is 20.07 vs. the industry median of 6.00, Accent Microcell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Drug Manufacturers company?
The median ROE % among Drug Manufacturers companies is 6.00, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current ROE % of 18.44% is 207.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median ROE % is 6.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current ROE % is 18.44%, which is near median its own 10-year median of 20.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current ROE % of 18.44%. The current ROE % is 18.44%, which is near median its 10-year median of 20.07 and 207.3% above the Drug Manufacturers industry median of 6.00. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current ROE % is 18.44% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score
Get the complete analysis for NSE:ACCENTMIC
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 